Learn more

GAUNGZHOU SUREXAM BIOLOG TECHNOLOGY CO LTD

Overview
  • Total Patents
    12
About

GAUNGZHOU SUREXAM BIOLOG TECHNOLOGY CO LTD has a total of 12 patent applications. Its first patent ever was published in 2009. It filed its patents most often in China. Its main competitors in its focus markets biotechnology are SHENZHEN BLOOD CT, MIRDETECT GMBH and NANJING ADICON CLINICAL LABORATORIES CO LTD.

Patent filings in countries

World map showing GAUNGZHOU SUREXAM BIOLOG TECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 12

Patent filings per year

Chart showing GAUNGZHOU SUREXAM BIOLOG TECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Biotechnology

Focus technologies

# Technology
#1 Measuring microorganism processes

Top inventors

# Name Total Patents
#1 Xu Jiasen 10
#2 Yu Gang 3
#3 Guo Jing 3
#4 Qin Huijuan 3
#5 Gan Dancui 2
#6 Li Guoqiang 2
#7 Huiyi Yang 2
#8 Jiasen Xu 2
#9 Jiaying He 2
#10 Tan Xiaoxia 1

Latest patents

Publication Filing date Title
CN102304567A Polymorphic detection specific primers and liquid phase chip in 8 q 24 section of chromosome
CN102304569A Specific primers and liquid phase chip for polymorphic detection of age-related maculopathy susceptibility 2 (ARMS2) gene and high temperature factor A-1 (HTRA1) gene
CN102304568A Specific primers and liquid phase chip for polymorphic detection of fibroblast growth factor (FGFR2) gene
CN102304566A Specific primers and liquid phase chip for polymorphic detection of human hedgehog interacting protein (HHIP) gene
CN102304565A Specific primers and liquid phase chip for polymorphic detection of hemochromatosis (HFE) gene
CN102154455A Specific primer and liquid phase chip for SNP (Single Nucleotide Polymorphism) detection of CYP2C9 (Cytochrome P4502C9)
CN102277413B Specific primer and liquid-phase chip for SNP detection of COX-1 genes
CN102234683A Liquid phase chip for detecting EGFR (epidermal growth factor receptor) gene mutation
CN102234685A Liquid phase chip for detecting PIK3CA (phosphoinositide-3-kinase, catalytic, alpha) gene mutation
CN102312007A Specific sequences and liquid-phase chip for SNP (single nucleotide polymorphism) detection of genes related to therapeutic effectiveness of platinum medicaments
CN102312009A Specific sequences and liquid-phase chip for SNP (single nucleotide polymorphism) detection of genes related to therapeutic effectiveness of platinum medicaments
CN102312008A Specific sequences and liquid-phase chip for SNP (single nucleotide polymorphism) detection of genes related to therapeutic effectiveness of platinum medicaments